Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Fish Shellfish Immunol ; 99: 184-189, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32035168

RESUMO

The intestine is the primary target of pathogenic microbes during invasion. However, the interaction of Vibrio parahaemolyticus (V. parahaemolyticus) with intestinal epithelial cells and its effects on the intestinal function of Litopenaeus vannamei (L. vannamei) are poorly studied. Therefore, the aim of this study was to investigate the influence of V. parahaemolyticus infection on intestinal barrier function and nutrient absorption in L. vannamei. In the present study, a total of 90 shrimp were randomly divided into two groups including the control group and V. parahaemolyticus infection group (final concentration of 1 × 105 CFU/mL), with three replicates per group. The result showed that compared with the control group, V. parahaemolyticus infection increased (P < 0.05) serum diamine oxidase activity and endotoxin quantification, and down-regulated (P < 0.05) the mRNA levels of intestinal peroxinectin, integrin, midline fasciclin at 48 h and 72 h; V. parahaemolyticus infection decreased (P < 0.05) the mRNA expression of intestinal amino acid transporter (CAT1, EAAT3 and ASCT1) and glucose transporter (SGLT-1, GLUT) at 24 h, 48 h and 72 h, and increased (P < 0.05) serum glucose and amino acid (Asp, Thr, Ser, Glu, Gly, Ala, Val, Ile, Leu, Tyr, Phe, Lys, His and Arg) concentration at 24 h. The results indicated that V. parahaemolyticus infection increased intestinal permeability, inhibited absorption of glucose and amino acid in L. vannamei.


Assuntos
Enteropatias/veterinária , Intestinos/fisiopatologia , Nutrientes/metabolismo , Penaeidae/microbiologia , Vibrioses/veterinária , Sistemas de Transporte de Aminoácidos/genética , Aminoácidos/metabolismo , Animais , Células Epiteliais/microbiologia , Células Epiteliais/patologia , Glucose/metabolismo , Proteínas Facilitadoras de Transporte de Glucose/genética , Enteropatias/patologia , Intestinos/citologia , Intestinos/microbiologia , Permeabilidade , Vibrioses/patologia , Vibrio parahaemolyticus
2.
Innate Immun ; 22(5): 344-52, 2016 07.
Artigo em Inglês | MEDLINE | ID: mdl-27189428

RESUMO

The present study was aimed at investigating whether dietary anemonin could alleviate LPS-induced intestinal injury and improve intestinal barrier restoration in a piglet model. Eighteen 35-d-old pigs were randomly assigned to three treatment groups (control, LPS and LPS+anemonin). The control and LPS groups were fed a basal diet, and the LPS + anemonin group received the basal diet + 100 mg anemonin/kg diet. After 21 d of feeding, the LPS- and anemonin-treated piglets received i.p. administration of LPS; the control group received saline. At 4 h post-injection, jejunum samples were collected. The results showed that supplemental anemonin increased villus height and transepithelial electrical resistance, and decreased crypt depth and paracellular flux of dextran (4 kDa) compared with the LPS group. Moreover, anemonin increased tight junction claudin-1, occludin and ZO-1 expression in the jejunal mucosa, compared with LPS group. Anemonin also decreased TNF-α, IL-6, IL-8 and IL-1ß mRNA expression. Supplementation with anemonin also increased TGF-ß1 mRNA and protein expression, Smad4 and Smad7 mRNA expressions, and epidermal growth factor and epidermal growth factor receptor (EGFR) mRNA expression in the jejunal mucosa. These findings suggest that dietary anemonin attenuates LPS-induced intestinal injury by improving mucosa restoration, alleviating intestinal inflammation and influencing TGF-ß1 canonical Smads and EGFR signaling pathways.


Assuntos
Anti-Inflamatórios/uso terapêutico , Receptores ErbB/metabolismo , Furanos/uso terapêutico , Gastrite/tratamento farmacológico , Mucosa Intestinal/efeitos dos fármacos , Junções Íntimas/efeitos dos fármacos , Fator de Crescimento Transformador beta1/metabolismo , Animais , Células Cultivadas , Claudina-1/metabolismo , Modelos Animais de Doenças , Impedância Elétrica , Fator de Crescimento Epidérmico/genética , Fator de Crescimento Epidérmico/metabolismo , Gastrite/imunologia , Humanos , Mucosa Intestinal/imunologia , Mucosa Intestinal/patologia , Lipopolissacarídeos/imunologia , Ranunculaceae/imunologia , Regeneração , Transdução de Sinais/efeitos dos fármacos , Proteína Smad4/metabolismo , Proteína Smad7/genética , Proteína Smad7/metabolismo , Sus scrofa , Junções Íntimas/metabolismo , Fator de Crescimento Transformador beta1/genética
3.
Innate Immun ; 22(3): 152-61, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26921254

RESUMO

In this study we investigated whetherL-cysteine (L-cys) could alleviate LPS-induced intestinal disruption and its underlying mechanism. Piglets fed with anL-cys-supplemented diet had higher average daily gain.L-cys alleviated LPS-induced structural and functional disruption of intestine in weanling piglets, as demonstrated by higher villus height, villus height (VH) to crypt depth (CD) ratio, and transepithelial electrical resistance (TER) and lower FITC-dextran 4 (FD4) kDa flux in jejunum and ileum. Supplementation withL-cys up-regulated occludin and claudin-1 expression, reduced caspase-3 activity and enhanced proliferating cell nuclear antigen expression of jejunum and ileum relative to LPS group. Additionally,L-cys suppressed the LPS-induced intestinal inflammation and oxidative stress, as demonstrated by down-regulated TNF-α, IL-6 and IL-8 mRNA levels, increased catalase, superoxide dismutase, glutathione peroxidase activity, glutathione (GSH) contents and the ratio of GSH and oxidized glutathione in jejunum and ileum. Finally, a diet supplemented withL-cys inhibited NF-κB(p65) nuclear translocation and elevated NF erythroid 2-related factor 2 (Nrf2) translocation compared with the LPS group. Collectively, our results indicated the protective function ofL-cys on intestinal mucosa barrier may closely associated with its anti-inflammation, antioxidant and regulating effect on the NF-κB and Nrf2 signaling pathways.


Assuntos
Cisteína/uso terapêutico , Inflamação/tratamento farmacológico , Mucosa Intestinal/efeitos dos fármacos , Fator 2 Relacionado a NF-E2/metabolismo , NF-kappa B/metabolismo , Animais , Suplementos Nutricionais , Inflamação/induzido quimicamente , Interleucina-6/metabolismo , Interleucina-8/metabolismo , Mucosa Intestinal/imunologia , Mucosa Intestinal/patologia , Lipopolissacarídeos/imunologia , Estresse Oxidativo/efeitos dos fármacos , Transporte Proteico/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Suínos , Fator de Necrose Tumoral alfa/metabolismo
4.
Innate Immun ; 20(5): 478-86, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23956359

RESUMO

This study explored whether zinc oxide (ZnO) supplementation could alleviate weanling-induced intestinal injury through TLR and NOD-like receptor signaling pathways. Twelve early-weanling piglets were allotted to two dietary treatments (control vs 2200 mg Zn/kg from ZnO) for 1 wk. The results showed that supplemental ZnO improved daily gain and feed intake, decreased post weaning scour scores, increased villus height and villus height:crypt depth ratio at the jejunal mucosa, and decreased diamine oxidase activity and endotoxin concentration in plasma. The intestinal mRNA levels of TLR4 and its downstream signals, including MyD88, IL-1 receptor-associated kinase 1 and TNF-α receptor-associated factor 6, were decreased, and the expressions of intestinal pro-inflammatory cytokines and chemokines were decreased simultaneously in the ZnO-supplemented piglets. Although NF-κB p65 mRNA abundance was not affected by ZnO supplementation, NF-κB p65 protein expression was down-regulated by ZnO. However, ZnO supplementation had no effect on intestinal expressions of NOD1 and NOD2, and their adaptor molecule receptor-interacting serine/threonine-protein kinase 2, as well as protein expressions of caspase-3 and heat shock protein 70. The results indicated that the protective effects of ZnO on intestinal integrity were closely related to decreasing the expressions of genes associated with inflammation through inhibiting the TLR4-MyD88 signaling pathways.


Assuntos
Expressão Gênica/efeitos dos fármacos , Inflamação/genética , Mucosa Intestinal/metabolismo , Intestinos/efeitos dos fármacos , Fator 88 de Diferenciação Mieloide/metabolismo , Receptor 4 Toll-Like/metabolismo , Óxido de Zinco/farmacologia , Animais , Quimiocinas/biossíntese , Citocinas/biossíntese , Dieta , Regulação para Baixo/efeitos dos fármacos , Ingestão de Alimentos/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/patologia , RNA Mensageiro/biossíntese , Sus scrofa , Suínos , Fator de Transcrição RelA/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA